[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 United States Bacterial Vaginosis Drug Market Report (Status and Outlook)

August 2018 | 84 pages | ID: 214BE6D54E5EN
LP Information

US$ 3,360.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In 2017, the Bacterial Vaginosis Drug market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In United States market, the top players include
  • Pfizer
  • Teva
  • Perrigo
  • Mylan
  • Lupin Pharmaceuticals
  • Prasco
  • West-Ward
  • Edenvridge
Split by product types/category, covering
  • Clindamycin
  • Metronidazole
  • Tinidazole
  • Other
Split by applications/end use industries, covers
  • Hospital
  • Drug Store
  • Other
2018-2023 UNITED STATES BACTERIAL VAGINOSIS DRUG MARKET REPORT (STATUS AND OUTLOOK)

1 BACTERIAL VAGINOSIS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Bacterial Vaginosis Drug
1.2 Bacterial Vaginosis Drug Market Segment by Types
  1.2.1 United States Bacterial Vaginosis Drug Sales Present Situation and Outlook by Types (2013-2023)
  1.2.2 United States Bacterial Vaginosis Drug Sales Market Share by Types in 2017
  1.2.3 Clindamycin
    1.2.3.1 Major Players of Clindamycin
  1.2.4 Metronidazole
    1.2.4.1 Major Players of Metronidazole
  1.2.5 Tinidazole
    1.2.5.1 Major Players of Tinidazole
  1.2.6 Other
    1.2.6.1 Major Players of Other
1.3 United States Bacterial Vaginosis Drug Market Segment by Applications/End Use Industries
  1.3.1 United States Bacterial Vaginosis Drug Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
  1.3.2 United States Bacterial Vaginosis Drug Sales Market Share by Applications in 2017
  1.3.2 Hospital
  1.3.3 Drug Store
  1.3.4 Other
1.4 United States Bacterial Vaginosis Drug Overview and Market Size (Value) (2013-2023)
  1.4.1 United States Market Bacterial Vaginosis Drug Overview
  1.4.2 United States Bacterial Vaginosis Drug Market Size (Value and Volume) Status and Forecast (2013-2023)

2 UNITED STATES BACTERIAL VAGINOSIS DRUG SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 United States Bacterial Vaginosis Drug Sales and Market Share by Players (2013-2018)
2.2 United States Bacterial Vaginosis Drug Revenue and Market Share by Players (2013-2018)
2.3 United States Bacterial Vaginosis Drug Average Price by Players in 2017
2.4 United States Bacterial Vaginosis Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Bacterial Vaginosis Drug Market Competitive Situation and Trends
  2.5.1 Bacterial Vaginosis Drug Market Concentration Rate
  2.5.2 Bacterial Vaginosis Drug Market Share of Top 3 and Top 5 Players in 2017
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BACTERIAL VAGINOSIS DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2013-2018)

3.1 United States Bacterial Vaginosis Drug Sales, Revenue, Market Share and Price by Type (2013-2018)
  3.1.1 United States Bacterial Vaginosis Drug Sales and Market Share by Type (2013-2018)
  3.1.2 United States Bacterial Vaginosis Drug Revenue and Market Share by Type (2013-2018)
  3.1.3 United States Bacterial Vaginosis Drug Price by Type (2013-2018)
3.2 United States Bacterial Vaginosis Drug Sales and Market Share by Application (2013-2018)
3.3 United States Market Bacterial Vaginosis Drug Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)

4 UNITED STATES BACTERIAL VAGINOSIS DRUG PLAYERS PROFILES AND SALES DATA

4.1 Pfizer
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Pfizer Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Pfizer News
4.2 Teva
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Teva Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Teva News
4.3 Perrigo
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Perrigo Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Perrigo News
4.4 Mylan
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Mylan Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Mylan News
4.5 Lupin Pharmaceuticals
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Lupin Pharmaceuticals Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Lupin Pharmaceuticals News
4.6 Prasco
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Prasco Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Prasco News
4.7 West-Ward
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 West-Ward Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 West-Ward News
4.8 Edenvridge
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Bacterial Vaginosis Drug Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Edenvridge Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Edenvridge News

5 UNITED STATES BACTERIAL VAGINOSIS DRUG MARKET FORECAST (2018-2023)

5.1 United States Bacterial Vaginosis Drug Sales, Revenue and Price Forecast (2018-2023)
  5.1.1 United States Bacterial Vaginosis Drug Sales and Growth Rate Forecast (2018-2023)
  5.1.2 United States Bacterial Vaginosis Drug Revenue and Growth Rate Forecast (2018-2023)
  5.1.3 United States Bacterial Vaginosis Drug Price Trend Forecast (2018-2023)
5.2 United States Bacterial Vaginosis Drug Sales Forecast by Type (2018-2023)
5.3 United States Bacterial Vaginosis Drug Sales Forecast by Application (2018-2023)

6 PRODUCTION COST ANALYSIS OF BACTERIAL VAGINOSIS DRUG

6.1 Main Raw Materials of Bacterial Vaginosis Drug
  6.1.1 List of Bacterial Vaginosis Drug Main Raw Materials
  6.1.2 Bacterial Vaginosis Drug Main Raw Materials Price Analysis
  6.1.3 Bacterial Vaginosis Drug Raw Materials Major Suppliers
  6.1.4 Bacterial Vaginosis Drug Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Bacterial Vaginosis Drug
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Bacterial Vaginosis Drug Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bacterial Vaginosis Drug Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Bacterial Vaginosis Drug Major Players in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Bacterial Vaginosis Drug Distributors/Traders List in United States

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source
LIST OF TABLES AND FIGURES

Figure Picture of Bacterial Vaginosis Drug
Table Product Specifications of Bacterial Vaginosis Drug
Figure United States Bacterial Vaginosis Drug Sales (volume) for Each Type (2013-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Types in 2017
Table Types of Bacterial Vaginosis Drug
Figure Product Picture of Clindamycin
Table Major Players of Clindamycin
Figure Product Picture of Metronidazole
Table Major Players of Metronidazole
Figure Product Picture of Tinidazole
Table Major Players of Tinidazole
Figure Product Picture of Other
Table Major Players of Other
Figure United States Bacterial Vaginosis Drug Sales Present Situation and Outlook by Applications (2013-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Applications in 2017
Table Applications of Bacterial Vaginosis Drug
Figure Hospital Examples
Figure Drug Store Examples
Figure Other Examples
Figure United States Bacterial Vaginosis Drug Revenue (Million USD) Status and Forecast (2013-2023)
Figure United States Bacterial Vaginosis Drug Sales (Volume) Status and Forecast (2013-2023)
Table United States Bacterial Vaginosis Drug Sales by Players (2013-2018)
Table United States Bacterial Vaginosis Drug Sales Market Share (%) by Players (2013-2018)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Players in 2016
Figure United States Bacterial Vaginosis Drug Sales Market Share by Players in 2017
Table United States Bacterial Vaginosis Drug Revenue (Million USD) by Players (2013-2018)
Table United States Bacterial Vaginosis Drug Revenue Market Share (%) by Players (2013-2018)
Figure United States Bacterial Vaginosis Drug Revenue Market Share by Players in 2016
Figure United States Bacterial Vaginosis Drug Revenue Market Share by Players in 2017
Figure United States Bacterial Vaginosis Drug Average Price by Players in 2017
Table United States Bacterial Vaginosis Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Bacterial Vaginosis Drug Product Types
Figure Bacterial Vaginosis Drug Market Share of Top 3 Players in 2017
Figure Bacterial Vaginosis Drug Market Share of Top 5 Players in 2017
Table United States Bacterial Vaginosis Drug Sales by Type (2013-2018)
Table United States Bacterial Vaginosis Drug Sales Market Share by Type (2013-2018)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Type in 2013
Figure United States Bacterial Vaginosis Drug Sales Market Share by Type in 2017
Table United States Bacterial Vaginosis Drug Revenue (Million USD) by Type (2013-2018)
Table United States Bacterial Vaginosis Drug Revenue Market Share by Type (2013-2018)
Figure United States Bacterial Vaginosis Drug Revenue Market Share by Type in 2013
Figure United States Bacterial Vaginosis Drug Revenue Market Share by Type in 2017
Table United States Bacterial Vaginosis Drug Price by Type (2013-2018)
Table United States Bacterial Vaginosis Drug Sales by Application (2013-2018)
Table United States Bacterial Vaginosis Drug Sales Market Share by Application (2013-2018)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Application (2013-2018)
Figure United States Bacterial Vaginosis Drug Sales Market Share by Application in 2017
Table United States Market Bacterial Vaginosis Drug Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Bacterial Vaginosis Drug Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Bacterial Vaginosis Drug Market Share (2012-2017)
Table Perrigo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Perrigo Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Perrigo Bacterial Vaginosis Drug Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Bacterial Vaginosis Drug Market Share (2012-2017)
Table Lupin Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Pharmaceuticals Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lupin Pharmaceuticals Bacterial Vaginosis Drug Market Share (2012-2017)
Table Prasco Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Prasco Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Prasco Bacterial Vaginosis Drug Market Share (2012-2017)
Table West-Ward Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table West-Ward Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure West-Ward Bacterial Vaginosis Drug Market Share (2012-2017)
Table Edenvridge Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Edenvridge Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Edenvridge Bacterial Vaginosis Drug Market Share (2012-2017)
Figure United States Bacterial Vaginosis Drug Sales and Growth Rate Forecast (2018-2023)
Figure United States Bacterial Vaginosis Drug Revenue and Growth Rate Forecast (2018-2023)
Figure United States Bacterial Vaginosis Drug Price Trend Forecast (2018-2023)
Table United States Bacterial Vaginosis Drug Sales Forecast by Type (2018-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share Forecast by Type (2018-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share Forecast by Type in 2023
Table United States Bacterial Vaginosis Drug Sales Forecast by Application (2018-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share Forecast by Application (2018-2023)
Figure United States Bacterial Vaginosis Drug Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Bacterial Vaginosis Drug Main Raw Materials Price Trend
Table Bacterial Vaginosis Drug Raw Materials Major Suppliers List
Figure Production Cost Structure of Bacterial Vaginosis Drug
Figure Bacterial Vaginosis Drug Manufacturing Process/Method
Figure Bacterial Vaginosis Drug Value Chain Analysis
Table Raw Materials Sources of Bacterial Vaginosis Drug Major Players in 2017
Table Major Buyers of Bacterial Vaginosis Drug
Table Bacterial Vaginosis Drug Distributors/Traders List in United States


More Publications